Edition:
United States

Health News

Photo

Amgen and Arrowhead to develop gene-therapies for heart disease 7:47am EDT

Amgen Inc said on Thursday it would buy a stake in Arrowhead Pharmaceuticals Inc and team up with the company to develop gene-silencing therapies for heart disease.

More Headlines

Photo

The cost of cheap drugs? Toxic Indian lake is 'superbug hotspot'

HYDERABAD, India Centuries ago, Indian princes would bathe in the cool Kazhipally lake in Medak. Now, even the poorest villagers here in India's baking south point to the barren banks and frothy water and say they avoid going anywhere near it.

World, United Nations 4:57am EDT

NBTY to genetically test herbal supplements under NY accord

NEW YORK NBTY Inc, one of the largest U.S. herbal supplement producers, has agreed to conduct an advanced form of genetic testing to ensure that its herbal products contain what their labels say they contain, New York's attorney general said on Wednesday.

Sep 28 2016

Actelion to investigate all-oral MS combination therapy

ZURICH Swiss biotech group Actelion Ltd will investigate an all-oral combination therapy for patients with relapsing multiple sclerosis (RMS), it said, calling it the first study of this approach for treating the neurological disorder.

1:16am EDT

Twitter may open door to people's thoughts on heart health

(Reuters Health) - Twitter may be a rich vein researchers can mine for data on what people think and say about cardiovascular disease, according to a new study.

Sep 28 2016

Health Watch Graphics